Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do a Duolingo stock analysis & discuss the risks and upside potential of DUOL stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
27 Aug 2025, 22:16 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to do a Duolingo stock analysis & discuss the risks and upside potential of DUOL stock
Source overview

AI-generated source summary

The video discusses Duolingo's stock performance, noting it has declined 41% over the past two months but remains up 50% over the last year. The speaker revisits a previous valuation, where he considered the stock overvalued at $370, with a fair value around $291. Currently, the stock is trading near $316. The analysis addresses Google Translate's new language learning tools as a potential threat, emphasizing that Duolingo's strength lies in its gamified, social learning experience. The financial metrics are provided: 41% revenue growth, 41% total bookings growth, 84% net income increase and 31.2 adjusted EBITDA margin. A chess course has over a million users. Monthly active users at 128.3 million, with daily active users at 47.7 million. Advertising revenue for the last quarter was $26.6 million. The company's net income margin is around 31%. The speaker also shows valuation model numbers using a 43 PE ratio targeting a price point of $582.66, with 84% upside potential.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail